John Yonchuk - Concepedia

Author

John Yonchuk

Also Known As

J YONCHUK, J Yonchuk, J.G. Yonchuk, John G Yonchuk, John G. Yonchuk, John Yonchuk

Publications

632

Citations

H-Index

Concepts

All Affiliations

John Yonchuk is an author at GlaxoSmithKline (United States) specializing in medicine, cell signaling, and pharmacology.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	360
2	Cell Biology	2	2	339
3	Health Sciences	1	1	21
4	Natural Sciences	1	1	295
5	Biochemistry	1	1	295

John Yonchuk

Publications

380

Citations

H-Index

Page 1

	Year	Citations
Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery Thomas G. Davies, William E. Wixted, Joseph E. Coyle, Journal of Medicinal Chemistry Molecular BiologyChemical BiologyRedox BiologyOxidative StressMonoacidic Inhibitors	2016	295
Danirixin: A Reversible and Selective Antagonist of the CXC Chemokine Receptor 2 Jakob Busch‐Petersen, Donald C. Carpenter, Miriam Burman, Journal of Pharmacology and Experimental Therapeutics Chemokine BiologyImmune RegulationImmunologyPharmacotherapyCellular Physiology	2017	44
Identification and characterisation of a salt form of Danirixin with reduced pharmacokinetic variability in patient populations Jackie C. Bloomer, Claire Ambery, Bruce E. Miller, European Journal of Pharmaceutics and Biopharmaceutics Salt FormPharmacokinetic VariabilityHealth SciencesPharmacological StudyMedicine	2017	21
Characterization of the Potent, Selective Nrf2 Activator, 3-(Pyridin-3-Ylsulfonyl)-5-(Trifluoromethyl)-2H-Chromen-2-One, in Cellular and In Vivo Models of Pulmonary Oxidative Stress John Yonchuk, Joseph P. Foley, Brian Bolognese, Journal of Pharmacology and Experimental Therapeutics	2017	20

Page 1